You might also be interested in:

Moritz Grossmann congratulates the New England Patriots with the SUPERBOWL watch

Glashütte (ots) - Loved by some, feared by others. There is no club where hearts and minds are as divided as ...

Qingdao, the cradle of The Wandering Earth and Crazy Alien

Qingdao, China (ots) - - Picture available via http://www.presseportal.de/en/bilder - - Picture ...

ForaCare Suisse AG forms service-oriented partnership with B. Braun (PHOTO)

St. Gallen (ots) - - Partnership to introduce innovative health management technologies. - Initial product offering ...

23.01.2019 – 16:01

Philogen

Philogen Announces Collaboration With Celgene

Siena, Italy (ots/PRNewswire)

Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Celgene, to discover and develop a new class of immunomodulatory therapeutics.

(Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg )

"We are extremely pleased to establish a new collaboration with Celgene, a leader in the discovery and development and commercialization of innovative therapies for patients with high unmet medical needs," commented Dr. Duccio Neri, Philogen's CEO.

No financial details of the agreement were released.

About Philogen

Philogen is a clinical-stage biotechnology company engaged in the discovery and development of novel biopharmaceutical products. Philogen's strategy is to deliver bioactive agents, for example cytokines or drugs to the site of disease using antibodies and ligands that specifically and efficiently target stromal antigens. This technology has generated a strong proprietary pipeline of clinical-stage products and also pre-clinical compounds in an array of disease indications. Philogen is headquartered in Siena, Italy, and has research activities at its subsidiary company Philochem in Zürich, Switzerland. Philogen is independently owned, and has signed agreements with several major pharmaceutical companies. For more information, please visit http://www.philogen.com .

Contact:

Christian Lizak
PhD
Senior Scientist - Business Development
+41-43-544-88-05
christian.lizak@philogen.com

Original content of: Philogen, transmitted by news aktuell

All Releases
Subscribe to Philogen
  • Printable version
  • PDF version

Places in this release

Topics in this relase

Additional press releases: Philogen